Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.49 |
| ▸ | TSHR | P16473 | 4/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.38 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11809594 | 0.94 | CYP3A4 (0.58) | CYP3A4TSHRTDP1MAPK1GPR35 | |
| SCHEMBL1876519 | 0.84 | CYP3A4 (0.67) | CYP3A4TSHRTDP1MAPK1GPR35 | |
| SCHEMBL13202978 | 0.82 | ALDH1A1 (0.50) | CYP3A4TSHRTDP1MAPK1GPR35 | |
| SCHEMBL11522696 | 0.80 | CYP1A2 (0.41) | CYP3A4TSHRTDP1MAPK1MAPT | |
| SCHEMBL11880900 | 0.79 | TSHR (0.51) | CYP3A4TSHRMAPK1GPR35MAPT | |
| SCHEMBL11762175 | 0.79 | MAPK1 (0.73) | CYP3A4TSHRTDP1MAPK1MAPT | |
| SCHEMBL8633720 | 0.78 | PARP1 (0.45) | CYP3A4TSHRTDP1MAPK1MAPT | |
| Fluchloralin SCHEMBL54746 | 0.76 | CYP3A4 (0.86) | CYP3A4TSHRTDP1MAPK1MAPT | |
| Fluchloralin SCHEMBL8534586 | 0.76 | CYP3A4 (0.86) | CYP3A4TSHRTDP1MAPK1MAPT | |
| SCHEMBL16577804 | 0.76 | CYP3A4 (0.70) | CYP3A4TSHRTDP1MAPK1GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| EP-3578542-B1 | COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-11-12 | — | — | EP | claimed |
| EP-3578543-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-08-20 | — | — | EP | claimed |
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | claimed |
| US-20250057161-A1 | USE OF CYCLODEXTRINS AS AGROCHEMICAL DELIVERY SYSTEM | ADAMA MAKHTESHIM LTD. (IL) | 2025-02-20 | — | — | US | claimed |
| US-20230247988-A1 | HERBICIDE COMBINATIONS | UPL LTD (IN) | 2023-08-10 | — | — | US | claimed |
| EP-4171230-A1 | HERBICIDE COMBINATIONS | UPL Limited (IN) | 2023-05-03 | — | — | EP | claimed |
| EP-3247698-B1 | CRYSTALLINE MODIFICATION OF PROPANIL | UPL LTD (IN) | 2022-10-19 | — | — | EP | claimed |
| EP-4046490-A1 | AN IMPROVED HERBICIDAL FORMULATION | UPL Limited (IN) | 2022-08-24 | — | — | EP | claimed |
| US-11419336-B2 | Herbicidal combination | UPL LTD (IN) | 2022-08-23 | — | — | US | claimed |
| EP-4007488-A1 | TRIPLOID CANNABIS PLANTS AND METHODS FOR GENERATING SAME | Canopy Growth Corporation (CA) | 2022-06-08 | — | — | EP | claimed |
| US-4226789-A | Removal of nitrosamines from denitroanilines by treatment with HCl | ELI LILLY AND COMPANY (US) | 1980-10-07 | — | — | US | claimed |
| US-4185035-A | REMOVAL OF NITROSAMINES WITH PHOSPHORUS HALIDES | ELI LILLY AND COMPANY (US) | 1980-01-22 | — | — | US | claimed |
| US-4127610-A | REMOVAL OF NITROSAMINES | ELI LILLY AND COMPANY (US) | 1978-11-28 | — | — | US | claimed |
| US-4077795-A | 2,4-DINITROANILINE DERIVATIVES | UNION CARBIDE CORPORATION (US) | 1978-03-07 | — | — | US | claimed |
| WO-2026101910-A1 | FUNGICIDAL FORMULATIONS CONTAINING ARYL AMIDINES AND METHODS OF USE | CORTEVA AGRISCIENCE LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| US-12616203-B2 | Use of 3-isoxazolidinones compounds as selective herbicides | FMC CORPORATION (US) | 2026-05-05 | — | — | US | disclosed |
| US-4011341-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3962307-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3726923-A | PROCESS FOR THE MANUFACTURE OF N,N-DICHLOROALKYL-2,6-DINITRO-4-ALKYL ANILINE | GLENFED FINANCIAL CORPORATION | 1973-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11419336-B2 | Herbicidal combination | DDT, AADAC, DPP4 | CYP3A4 296/4885TSHR 1254/4885TDP1 1931/4885 |
| US-20230247988-A1 | HERBICIDE COMBINATIONS | DDT, NOTUM, FAAH2 | CYP3A4 973/4885TSHR 2829/4885TDP1 1828/4885 |
| US-12616203-B2 | Use of 3-isoxazolidinones compounds as selective herbicides | CNPY2, CRY2, DDT | CYP3A4 318/4885TSHR 1156/4885TDP1 3691/4885 |
| US-20250057161-A1 | USE OF CYCLODEXTRINS AS AGROCHEMICAL DELIVERY SYSTEM | DDT, GYS2, ACHE | CYP3A4 175/4885TSHR 3713/4885TDP1 2654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.